ConsiGma Continuous Manufacturing

ConsiGma Continuous Manufacturing
Product Description

With continuous line running at customer’s site for almost two decades, GEA Pharma & Healthcare has, from the very beginning, led the field with flexible development options that improve commercial-scale production and enable greater process understanding to be achieved with smaller quantities of material. Also, the company’s experience in pharmaceutical oral solid dosage (OSD) production technologies and continuous processing experience in other industries, such as chemicals and food, gives GEA an edge when it comes to supporting the pharmaceutical industry in this game-changing switch from batch to continuous.

GEA Group

  • DE
  • 2016
    On CPHI since
  • 5000+
    Employees
Company types
Machinery and Equipment Supplier/Manufacturer
Primary activities
Technology
Specifications
  • Selling Points
    Product Features; Product Performance; Reputation; Sustainability
  • Supplied from
    Belgium

GEA Group

  • DE
  • 2016
    On CPHI since
  • 5000+
    Employees
Company types
Machinery and Equipment Supplier/Manufacturer
Primary activities
Technology

More Products from GEA Group (6)

  • GEA Pharma & Healthcare

    Product GEA Pharma & Healthcare

    The Flexibility You Want. The Quality You Need.

    Equipped with a wealth of product, customer and market knowledge, you can rely on GEA to deliver end-to-end support for your pharmaceutical manufacturing project. Whether it’s a flexible continuous processing line for an over-the-counter pill, a fully ...
  • NexGen Press

    Product NexGen Press

    GEA Pharma & Healthcare has long been recognized as a trusted supplier of cutting- edge tableting technology, with innovations that include
    • EXTENDED DWELL TIMES
    • a unique DUAL CONTROL system that independently and simultaneously measures and regulates both tablet weight and hardn...
  • Digital Canary for Better Protection

    Product Digital Canary for Better Protection

    Modern pharmaceutical equipment is designed to operate in a completely dust-tight manner; but, it’s absolutely critical to be fully prepared for worst-case scenarios, such as an unexpected containment breach. As the level of potentially dangerous airborne particles is often far below what ...
  • LYOVAC ECO Mode

    Product LYOVAC ECO Mode

    LYOVAC ECO Mode: a solution for tomorrow
    With a focus on saving both energy and media, GEA’s new LYOVAC® ECO Mode combines dynamic condenser temperature control and mushroom (chamber/condenser) valve regulation to optimize the lyophilization process.

    Our new algorithm changes the set point ...
  • Pharmaceutical Spray Drying

    Product Pharmaceutical Spray Drying

    GEA, has been a pioneer in all aspects of spray drying and has contracted and installed more than 10,000 plants worldwide. We have a a long history of serving the pharmaceutical industry, and our supply includes spray dryers for R&D and product development, as well as equipment and complete lines for c...
  • GEA XStream lab homogenizer

    Product GEA XStream lab homogenizer

    The new lab unit is available in two models: XStream Lab Homogenizer 1000 and 2000 with different options according to specific requirements and Pharma execution:

    • cGMP, CFR21 and GAMP certifications with data recorder
    • Frequency converter for variable flow-rate (external)
    • Min...

GEA Group resources (2)

  • News Forging industry partnerships to accelerate the uptake of continuous pharmaceutical manufacturing

    GEA and its partners are leading the way toward smaller, more flexible continuous processing technologies that are transforming the future of pharmaceutical development and manufacturing.
  • News Uniting innovation and sustainability in pharma

    GEA directs its focus toward the juncture of sustainability and innovation, igniting positive transformation across our organization and the expansive pharmaceutical sector. 

    Sustainability in pharmaceuticals encompasses layers of significance. Central to this is drug manufacturing, which carries substantial environmental implications, spanning resource usage, waste generation, and emissions entailed in production, packaging, and distribution. The collective adoption of eco-conscious practices within the life sciences sector serves as a collaborative effort to confront challenges such as pollution, climate change, and the depletion of vital resources.

    Embedded in this landscape is the critical challenge of resource conservation. Given the extensive raw materials, energy, and water consumed by pharmaceutical processes, the adoption of sustainable practices to curtail the use of invaluable natural resources ...